ArticleJournal of bioethical inquiry2026
Ethical Priorities Among Commercial Genomics Professionals : Survey Evidence Highlighting Diversity, Fragmented Privacy Law, and Human Rights Risks as Central Participant Concerns.
Article in Journal of bioethical inquiry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
This paper presents results from a key informant survey exploring ethical, legal, and social issues (ELSI) as perceived by professionals working in the U.S.-based private sector human genomics industry. Drawing on a structured survey of 111 participants-including researchers, executives, policy leads, and communications specialists-this study examines how industry insiders assess emerging ethical concerns across domains such as data privacy, race and ancestry, sociogenomics, commercialization, and government partnerships. The survey instrument was developed based on a prior interview phase and reflects concerns raised directly by professionals in the field. Quantitative responses were analysed for levels of concern and consensus, while open-text responses provided further insight into areas of divergence and organizational context. Respondents expressed high concern and consensus about lack of diversity in datasets, fragmented privacy regulation, and potential genomics collaborations with governments implicated in human rights abuses, though significant disagreement emerged around the appropriate use of race categories and socio-genomic applications. This preliminary exploration offers a glimpse into perspectives from a difficult sample population, and suggests entry points for future collaboration, policy, and critical scholarship.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.